| 2013 | c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5 | CANCER GENE THERAPY |
| 2013 | Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment: Inhibition of apoptosis by caspase degradation. | CELLULAR SIGNALLING |
| 2003 | dl-VSVG-LacZ, a VSV-G epitope incorporated adenoviurs exhibit marked enhancement in gene transduction efficiency | HUMAN GENE THERAPY |
| 2017 | Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
| YONSEI MEDICAL JOURNAL |
| 2001 | Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor
| GENE THERAPY |
| 2021 | Enhanced oncolytic adenoviral production by downregulation of death-domain associated protein and overexpression of precursor terminal protein
| SCIENTIFIC REPORTS |
| 2022 | Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment
| MOLECULAR THERAPY-ONCOLYTICS |
| 2014 | Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2019 | High levels of Daxx due to low cellular levels of HSP25 in murine cancer cells result in inefficient adenovirus replication
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2012 | HSP27 modulates survival signaling networks in cells treated with curcumin and TRAIL. | CELLULAR SIGNALLING |
| 2011 | MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation
| ONCOLOGY REPORTS |
| 2003 | Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer | VIRUS RESEARCH |
| 2017 | Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
| ONCOTARGET |
| 2015 | Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells | CELLULAR SIGNALLING |
| 2015 | Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest | CELLULAR SIGNALLING |
| 2016 | Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells | APOPTOSIS |
| 2018 | Targeting mutant KRAS with CRISPR-Cas9 controls tumor growth
| GENOME RESEARCH |
| 2018 | TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2013 | The effectiveness of the oncolytic activity induced by Ad5/F35 adenoviral vector is dependent on the cumulative cellular conditions of survival and autophagy | INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2011 | TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt
| INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2013 | TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex | CELLULAR SIGNALLING |
| 2000 | Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells | Cancer Letters |
| 2013 | Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA | CANCER GENE THERAPY |
